-+ 0.00%
-+ 0.00%
-+ 0.00%

Is IMAX (IMAX) Undervalued Following The Odyssey Buzz And New In Vehicle Partnership?

Simply Wall St·07/19/2026 04:30:55
Listen to the news

IMAX (IMAX) is back in focus after two catalysts: the upcoming Christopher Nolan film "The Odyssey," shot entirely on IMAX 70mm cameras, and a new in-vehicle entertainment partnership with Goer Dynamics and IMAX China.

See our latest analysis for IMAX.

After a softer 30 day share price return, down 11.46%, IMAX is still showing renewed interest, with a 90 day share price return of 9.18% and a 1 year total shareholder return of 38.11%, supported by fresh content and platform expansion news.

If you like the idea of cinematic technology meeting growth themes, it can be worth widening your research using the 18 top founder-led companies

After a 30 day pullback and a strong 1 year run, IMAX now sits between investors who see further upside from its content slate and new formats, and those who think most of the gain is already in the rear view mirror.

Most Popular Narrative: 16.2% Undervalued

Based on the most followed narrative, IMAX is viewed as undervalued, with a fair value of $46.82 versus the last close at $39.25, and that gap is grounded in specific growth and margin assumptions.

Operating leverage from cost discipline, capital-light joint-venture models, and advances in proprietary projection/distribution technology (e.g., streaming for live events) is driving sustained margin expansion and cash generation, directly benefiting net margins and enabling opportunistic reinvestment or shareholder returns.

Read the complete narrative.

There is a clear blueprint behind that $46.82 fair value. It hinges on faster revenue growth, a sharp step up in profitability, and a lower earnings multiple. Want to see which assumptions do the heavy lifting in that model and how they connect back to IMAX's premium screen network and content pipeline?

Result: Fair Value of $46.82 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, IMAX's dependence on blockbuster releases and high capital spending on new systems means that weaker film slates or slower installations could quickly challenge that undervalued story.

Find out about the key risks to this IMAX narrative.

Another View: What IMAX's P/E Ratio Is Telling You

There is a catch to the undervalued narrative around IMAX. On earnings, the stock trades on a P/E of 58.7x, compared with 21.1x for the US Entertainment industry and a fair ratio estimate of 27.5x. That sort of gap can point to richer expectations and a narrower margin for error. Is this a premium you are comfortable paying?

For a closer look at how this earnings based view compares with the implied opportunity, including where the ratio could realistically migrate over time, See what the numbers say about this price — find out in our valuation breakdown.

NYSE:IMAX P/E Ratio as at Jul 2026
NYSE:IMAX P/E Ratio as at Jul 2026

Next Steps

If this mix of optimism and caution around IMAX resonates, do not wait for the crowd to decide the story for you. Instead, take a closer look at the balance of potential upsides and watch points in the 4 key rewards and 1 important warning sign

Looking for more IMAX style investment ideas?

If IMAX has you thinking about what else could fit your portfolio, do not leave it there. Broaden your watchlist now so you are not reacting after the next move.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.